NCT01908660View on ClinicalTrials.gov

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

CompletedOBSERVATIONAL
Enrollment

192

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Interventions
DRUG

antiretroviral drugs

zidovudine lamivudine emtricitabine abacavir tenofovir nevirapine efavirenz etravirine rilpivirine lopinavir atazanavir fosamprenavir darunavir raltegravir maraviroc ritonavir

Trial Locations (1)

41014

Hospital Universitario de Valme, Seville

All Listed Sponsors
collaborator

Hospital Universitario Virgen de la Victoria

OTHER

collaborator

Hospital Universitario Reina Sofia de Cordoba

OTHER_GOV

collaborator

Hospital Torrecárdenas

UNKNOWN

collaborator

Hospital de la Línea de la Concepción

UNKNOWN

collaborator

Hospital Poniente

UNKNOWN

collaborator

Hospital Universitario Virgen Macarena

OTHER

collaborator

Complejo Hospitalario de Especialidades Juan Ramón Jimenez

OTHER

lead

Valme University Hospital

OTHER

NCT01908660 - Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions | Biotech Hunter | Biotech Hunter